INmune Bio Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About INmune Bio Inc.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
/ 
Frequently asked questions
To buy INmune Bio Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for INmune Bio Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for INmune Bio Inc. is INMB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
INmune Bio Inc. has its primary listing on NASDAQ (Small cap). You can trade INmune Bio Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, INmune Bio Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include INmune Bio Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like INmune Bio Inc..